Your browser is no longer supported. Please, upgrade your browser.
Settings
CHRS Coherus BioSciences, Inc. daily Stock Chart
CHRS [NASD]
Coherus BioSciences, Inc.
Index- P/E- EPS (ttm)-2.66 Insider Own0.30% Shs Outstand65.67M Perf Week17.25%
Market Cap1.30B Forward P/E- EPS next Y-0.16 Insider Trans-1.50% Shs Float63.86M Perf Month35.95%
Income-185.00M PEG- EPS next Q-0.30 Inst Own97.45% Short Float11.00% Perf Quarter36.41%
Sales37.10M P/S35.01 EPS this Y28.20% Inst Trans5.10% Short Ratio8.15 Perf Half Y63.74%
Book/sh-0.56 P/B- EPS next Y84.50% ROA-120.30% Target Price28.60 Perf Year27.61%
Cash/sh1.47 P/C13.47 EPS next 5Y23.00% ROE- 52W Range8.32 - 20.66 Perf YTD118.56%
Dividend- P/FCF- EPS past 5Y-14.00% ROI- 52W High-4.27% Beta3.55
Dividend %- Quick Ratio3.80 Sales past 5Y- Gross Margin94.00% 52W Low137.74% ATR0.95
Employees243 Current Ratio3.80 Sales Q/Q- Oper. Margin- RSI (14)77.81 Volatility5.78% 5.86%
OptionableYes Debt/Eq- EPS Q/Q60.70% Profit Margin- Rel Volume1.86 Prev Close19.05
ShortableYes LT Debt/Eq- EarningsMay 09 AMC Payout- Avg Volume862.06K Price19.78
Recom1.70 SMA2020.72% SMA5029.81% SMA20039.44% Volume1,599,591 Change3.83%
May-07-19Initiated H.C. Wainwright Buy $28
Aug-28-18Initiated H.C. Wainwright Buy $28
Mar-09-18Reiterated Maxim Group Buy $20 → $15
Aug-08-17Reiterated JP Morgan Overweight $32 → $25
Jun-13-17Reiterated Maxim Group Buy $44 → $40
May-05-17Initiated BMO Capital Markets Outperform $54
Oct-19-16Initiated Robert W. Baird Outperform $40
Sep-07-16Initiated Maxim Group Buy $43
Jul-27-16Initiated Citigroup Buy $36
Jan-20-16Initiated Credit Suisse Outperform
May-15-19 02:10AM  Edited Transcript of CHRS earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-13-19 11:30AM  2 Drug Stocks to Buy as Health Care Suffers, According to JPMorgan Barrons.com
May-09-19 07:54PM  Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript Motley Fool
05:35PM  Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:24PM  Coherus BioSciences: 1Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial Results GlobeNewswire
May-08-19 04:04PM  Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ? Insider Monkey
May-02-19 05:00PM  Coherus BioSciences and Amgen Settle Trade Secrets Action GlobeNewswire
09:30AM  Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences GlobeNewswire
Apr-26-19 06:58AM  Moving Average Crossover Alert: Coherus BioSciences Zacks
Apr-25-19 09:27AM  The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences Zacks
Apr-24-19 09:11AM  5 Biotech Stocks Defying the Medicare-for-All Scare Zacks
Apr-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Apr-09-19 08:41AM  Coherus (CHRS) Catches Eye: Stock Jumps 6.9% Zacks -5.87%
Apr-08-19 04:32PM  Why Sony, AMC Entertainment Holdings, and Coherus BioSciences Jumped Today Motley Fool +6.90%
01:04PM  Here's Why Coherus BioSciences Popped Today Motley Fool
Apr-07-19 09:27AM  Read This Before Buying Coherus BioSciences, Inc. (NASDAQ:CHRS) Shares Simply Wall St.
Apr-05-19 04:00PM  Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA Net Sales GlobeNewswire
08:30AM  Coherus BioSciences to Report First Quarter Financial Results on May 9th GlobeNewswire
Mar-28-19 09:30AM  Coherus BioSciences Management to Present at H.C. Wainwright & Co. Global Life Sciences Conference GlobeNewswire
Mar-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -7.61%
Mar-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Mar-18-19 09:30AM  Coherus BioSciences Appoints Thomas Fitzpatrick Chief Legal Officer GlobeNewswire
Mar-05-19 08:24PM  Edited Transcript of CHRS earnings conference call or presentation 28-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
08:30AM  New Research: Key Drivers of Growth for American Tower Corporation (REIT), Lowe's Companies, Mimecast, Live Nation Entertainment, Intercept Pharmaceuticals, and Coherus BioSciences Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-28-19 07:10PM  Coherus BioSciences Inc (CHRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:30PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-26-19 09:30AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March GlobeNewswire -6.55%
Feb-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Feb-14-19 09:30AM  Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th GlobeNewswire
Feb-11-19 02:46PM  Here's Why Coherus BioSciences Rose 48.7% in January Motley Fool
Feb-07-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-25-19 12:00PM  Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgens Humira Biosimilar Formulation GlobeNewswire +6.54%
08:00AM  Coherus BioSciences Announces Global Settlement with AbbVie Securing Rights to Commercialize its Adalimumab Biosimilar Candidate, CHS-1420 GlobeNewswire
Jan-18-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.49%
Jan-15-19 11:03AM  Coherus BioSciences, Inc. (NASDAQ:CHRS) Is Expected To Breakeven Simply Wall St.
Jan-14-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-07-19 09:25AM  Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners GlobeNewswire +18.22%
Jan-02-19 09:30AM  Coherus BioSciences Management to Present at The 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-18 10:53AM  Edited Transcript of CHRS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -7.98%
Dec-19-18 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Dec-13-18 01:36AM  Edited Transcript of CHRS earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
Dec-12-18 12:13AM  Should You Buy Coherus Biosciences Inc (CHRS)? Insider Monkey
Dec-03-18 07:40AM  Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences Discovering Underlying Factors of Influence GlobeNewswire
Nov-30-18 09:30AM  Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS GlobeNewswire
Nov-29-18 07:52AM  Coherus BioSciences (CHRS): Moving Average Crossover Alert Zacks
Nov-27-18 06:00PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -5.79%
Nov-16-18 10:20AM  Is Coherus BioSciences Incs (NASDAQ:CHRS) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-12-18 08:00AM  Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference GlobeNewswire +8.85%
Nov-08-18 05:03PM  Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount Reuters
05:02PM  Coherus BioSciences: 3Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2018 Financial Results GlobeNewswire
Nov-02-18 01:41PM  U.S. FDA Approves UDENYCA (pegfilgrastim-cbqv) GlobeNewswire +6.03%
Oct-24-18 09:15AM  New Research: Key Drivers of Growth for UnitedHealth Group, The Wendy's Co., Xenia Hotels & Resorts, TopBuild, Coherus BioSciences, and Virtu Financial Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -10.09%
Oct-22-18 08:00AM  Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th GlobeNewswire
Oct-11-18 03:02PM  Here's Why Coherus BioSciences Fell 18.1% in September Motley Fool
Oct-09-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-26-18 12:32PM  Amgen's Neulasta Has a New Competitor in Europe GuruFocus.com
Sep-25-18 01:38PM  Coherus BioSciences Receives European Commission Approval for UDENYCA (Pegfilgrastim Biosimilar) GlobeNewswire
Sep-21-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-17-18 08:00AM  Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October GlobeNewswire
Sep-12-18 12:27PM  Edited Transcript of CHRS earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-31-18 07:50AM  Research Report Identifies Holly Energy Partners, First Merchants, Enbridge Energy Management, Activision Blizzard, Coherus BioSciences, and Kala Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-20-18 08:00AM  Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September GlobeNewswire
Aug-17-18 05:30PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Aug-08-18 06:14PM  Coherus BioSciences: 2Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-18 09:36AM  Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA (Pegfilgrastim Biosimilar Candidate) GlobeNewswire
08:20AM  Market Trends Toward New Normal in United Technologies, Paychex, Coherus BioSciences, InfraREIT, Cousins Properties, and Engility Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-25-18 04:05PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jul-24-18 08:00AM  Coherus BioSciences to Report Second Quarter 2018 Financial Results on August 8th GlobeNewswire
Jul-18-18 12:14PM  Here's Why Coherus Biosciences Rose Over 21% Today Motley Fool +20.13%
Jul-06-18 07:20AM  Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE
Jun-26-18 08:40AM  Implied Volatility Surging for Coherus BioSciences (CHRS) Stock Options Zacks
Jun-22-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.52%
May-25-18 09:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
May-22-18 07:38PM  Coherus Prices Public Offering of Common Stock GlobeNewswire
May-21-18 04:15PM  Coherus Announces Proposed Public Offering of Common Stock GlobeNewswire
May-17-18 07:10AM  Blog Exposure - Xenon Announced Presentation of Positive XEN1101 TMS Pharmacodynamic Phase-1 Data at 14th Eilat Conference ACCESSWIRE
May-14-18 12:39PM  U.S. Food and Drug Administration Accepts and Acknowledges Coherus BioSciences Biologics License Application of CHS-1701 (Pegfilgrastim Biosimilar Candidate) for Review GlobeNewswire
May-10-18 05:14PM  Coherus BioSciences: 1Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and First Quarter 2018 Financial Results GlobeNewswire
09:00AM  Coherus BioSciences Appoints Samuel Nussbaum, M.D. to Board of Directors GlobeNewswire
May-03-18 09:16AM  Coherus BioSciences Re-Submits Biologics License Application for CHS-1701 (Pegfilgrastim Biosimilar Candidate) GlobeNewswire +17.32%
May-01-18 09:00AM  Coherus BioSciences Management to Present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada GlobeNewswire
Apr-24-18 09:00AM  Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th GlobeNewswire
Apr-19-18 04:45PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Apr-02-18 09:00AM  Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco GlobeNewswire -7.24%
Mar-16-18 07:00AM  Free Post Earnings Research Report: Cambrex Achieved Record Quarterly Revenue; EPS Climbed 4% ACCESSWIRE
Mar-13-18 04:15PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Mar-09-18 04:33PM  Why II-VI, Coherus Biosciences, and El Pollo Loco Holdings Jumped Today Motley Fool +30.22%
04:20PM  How This Small-Cap Biotech Plans To Chip Away At Amgen's Biggest Drugs Investor's Business Daily
04:06PM  Edited Transcript of CHRS earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
11:49AM  Why Coherus Biosciences Is Skyrocketing Today Motley Fool
05:03AM  Coherus BioSciences reports 4Q loss Associated Press
Mar-08-18 04:00PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
01:15PM  Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-18 09:00AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March GlobeNewswire
Feb-27-18 09:00AM  Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th GlobeNewswire
Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ranibizumab and CHS-2020 for aflibercept that is in preclinical development; and CHS-131, small molecule therapeutic candidate and other metabolic conditions. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Viret Jean-FredericChief Financial OfficerMar 20Sale14.923,00044,76213,185Mar 22 04:05 PM
Viret Jean-FredericChief Financial OfficerSep 21Option Exercise13.507409,9904,519Sep 25 04:05 PM
FINCK BARBARA KChief Medical OfficerSep 10Option Exercise1.421,7602,49938,803Sep 12 04:05 PM
FINCK BARBARA KChief Medical OfficerSep 10Sale18.581,76032,69937,043Sep 12 04:05 PM
HEALY JAMESDirectorAug 29Sale20.5025,000512,5002,868,221Aug 31 05:23 PM
FINCK BARBARA KChief Medical OfficerAug 13Option Exercise1.421,7602,49938,803Aug 15 04:05 PM
FINCK BARBARA KChief Medical OfficerAug 13Sale19.021,76033,48037,043Aug 15 04:05 PM
Viret Jean-FredericChief Financial OfficerJul 23Sale18.569,291172,4723,779Jul 25 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 10Option Exercise1.421,2601,78938,303Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 10Sale15.001,26018,90037,043Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 09Option Exercise1.4250071037,543Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJul 09Sale15.035007,51537,043Jul 11 04:05 PM
FINCK BARBARA KChief Medical OfficerJun 18Option Exercise1.421,7602,49938,803Jun 20 04:09 PM
FINCK BARBARA KChief Medical OfficerJun 18Sale15.001,76026,40037,043Jun 20 04:09 PM